RELEVANT PUBLICATIONS

From Infectious Disease to Personalized Cancer Vaccines: Regulatory T cell Epitopes Determine Patient Outcomes and Suppress Neoantigen Responses

The 33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2018),

November 2018

Ancer-designed CT26 RNA replicon neo-epitope vaccine induces multi-functional CD4 and CD8 T cell responses

International Society for Vaccines (ISV) Annual Congress,

October 2018

Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer: Non-Self-Like Neo-Epitopes as a Prognostic Biomarker

Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference,

September 2018

Highly efficient selection of tumor neoantigens improves therapeutic cancer vaccine efficacy 

The 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019),

November 2019

© Copyright Epivax Oncology 2019